Regenerative Medicine Innovation Project Workshop in December

Oct 24, 2017

On December 6-7, 2017, the NIH and FDA will be hosting a Regenerative Medicine Innovation Workshop. The meeting will explore the state of regenerative medicine science involving adult stem cells, with a focus on approaches to the development of safe and effective products.

Sessions will emphasize cross-cutting issues with broad applicability to many areas of regenerative medicine clinical research. Presentations and case studies in specific clinical disciplines will focus on product development and clinical applications. There will also be regulatory science sessions dedicated to issues and opportunities in preclinical studies and clinical trial development. Panel discussions will focus on scientific, technical, and operational challenges as well as strategies for enabling major transformative advances and the development of clinical applications using adult stem cells.

More information, including an agenda and how to register, please visit:

RFA for Collaborative Computational Tools for the Human Cell Atlas

Aug 1, 2017

The Human Cell Atlas is a global effort to create a reference atlas of all cells in the healthy human body as a resource for studies of health and disease.

This endeavor will generate molecular and imaging data across a range of modalities and spatial scales, requiring new probabilistic and integrative approaches for analysis and interpretation, systematic comparison of methods on benchmark datasets, and mechanisms for disseminating these methods to a wide community.

The Chan Zuckerberg Initiative seeks applications for the development of computational tools, algorithms, visualizations, and benchmark datasets in support of this endeavor. Full details here.

Applications due August 28, 2017 by 5:00 PM PT


To access the full RFA, including details on the project specifications, project requirements, eligibility, key dates, and contact information, click here.

To access the full application instructions, click here.

Questions about the RFA? Join us for a Reddit AMA on Monday, August 14, from 10:00AM - 12:00PM PT. You can also email us at

Funding opportunities in Regenerative Medicine FOAs

Apr 28, 2017

These FOAs solicit competitive supplements that focus on innovative solutions to well-recognized challenges in the development of safe and effective regenerative medicine therapies. Emphasis will be given to request that address critical issues in product development relevant for regulatory submissions. Areas of focus may include improved tools, methods, standards, or applied science that support a better understanding and improved evaluation of product manufacturing, quality, safety, or effectiveness.

Eligible award mechanisms for competitive supplements are the R41/42, R43/44, U01, U54, UM1, UM2, UC4, U24, R01, R24, P50, and P41. The twelve Regenerative Medicine FOAs have published in the NIH Guide and may be accessed at the links below. Additional information about the Regenerative Medicine Innovation Project, including a set of Frequently Asked Questions, can be found at

RFA-HL-17-023 , R43 /R44 Small Business Innovation Research (SBIR) Grant - Phase I, Phase II, Phase IIB, and Fast Track

RFA-HL-17-024 , R41 /R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, Phase IIB, and Fast Track

RFA-HL-17-025 , U54 Specialized Center- Cooperative Agreements

RFA-HL-17-026 , UM1 Research Project with Complex Structure Cooperative Agreement

RFA-HL-17-027 , UC4 High Impact Research and Research Infrastructure - Cooperative Agreement Programs

RFA-HL-17-028 , U24 Resource-Related Research Projects – Cooperative Agreements

RFA-HL-17-029 , R01 Research Project Grant

RFA-HL-17-030 , R24 Resource-Related Research Projects

RFA-HL-17-031 , UM2 Program Project or Center with Complex Structure Cooperative Agreement

RFA-HL-17-032 , P50 Specialized Center

RFA-HL-17-033 , P41 Biotechnology Resource Grants

RFA-HL-17-034 , U01 Research Project – Cooperative Agreements